XML 24 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flow from operating activities:    
Net income $ 319,605 $ 410,699
Adjustments to reconcile net income to cash flow from operating activities:    
Depletion, depreciation, and amortization 365,400 390,119
Deferred income taxes 169,634 216,959
Stock-based compensation 23,774 22,662
Noncash fair value derivative adjustments 46,296 (19,757)
Loss on early extinguishment of debt 44,651 0
Amortization of debt issuance costs and discounts 10,581 11,021
Impairment of assets 0 17,515
Other, net (3,570) 15,087
Changes in assets and liabilities, net of effects from acquisitions:    
Accrued production receivable (34,910) 3,221
Trade and other receivables (756) 11,010
Other current and long-term assets (1,199) 8,218
Accounts payable and accrued liabilities 52,672 (30,127)
Oil and natural gas production payable 31,111 5,014
Other liabilities (11,080) (35,515)
Net cash provided by operating activities 1,012,209 1,026,126
Cash flow used in investing activities:    
Oil and natural gas capital expenditures (688,270) (848,618)
Acquisitions of oil and natural gas properties (1,896) (155,636)
Bakken exchange transaction (10,385) 0
CO2 capital expenditures (72,929) (93,945)
Pipelines and plants capital expenditures (136,654) (231,459)
Purchases of other assets (29,680) (18,666)
Net proceeds from sales of oil and natural gas properties and equipment 6,312 33,973
Proceeds from sale of short-term investments 0 83,545
Other (18,201) (7,166)
Net cash used in investing activities (951,703) (1,237,972)
Cash flow provided by (used in) financing activities:    
Bank repayments (1,170,000) (970,000)
Bank borrowings 780,000 1,210,000
Repayment of senior subordinated notes (651,270) 0
Premium paid on repayment of senior subordinated notes (36,475) 0
Proceeds from issuance of senior subordinated notes 1,200,000 0
Costs of debt financing (20,026) (17)
Common stock repurchase program (215,197) (16,747)
Other (19,501) (6,049)
Net cash provided by (used in) financing activities (132,469) 217,187
Net increase (decrease) in cash and cash equivalents (71,963) 5,341
Cash and cash equivalents at beginning of period 98,511 18,693
Cash and cash equivalents at end of period $ 26,548 $ 24,034